This FAQ discusses bleeding rates associated with mechanical circulatory support and vascular access and closure techniques for successfully managing bleeding.
The goals of cardiogenic shock treatment are to restore blood flow and protect organs from damage. Learn more about signs, symptoms and treatment options.
Navin K. Kapur, MD, FACC, FSCAI, FAHA, discusses how acute cardiac unloading limits infarct scar formation in the context of the DTU-STEMI Pilot trial and Pivotal trial.
Rajiv Tayal, MD, discusses axillary access techniques for large bore procedures as well as other alternative access skills for advanced interventional operators.
The STEMI DTU pivotal trial is a prospective, multicenter, two-arm randomized controlled trial that plans to enroll 668 patients undergoing treatment for a STEMI heart attack.
Alexander Truesdell, MD, and Behnam Tehrani, MD, discuss improved outcomes after implementing a cardiogenic shock protocol at Inova Heart and Vascular Institute.
